Emergency department use by patients who received chimeric antigen receptor t cell infusion therapy

HIGHLIGHTS

• who: Demis N. Lipe and colleagues from the Arcellx Inc, United States The University of Utah, United States have published the paper: Emergency department use by patients who received chimeric antigen receptor T cell infusion therapy, in the Journal: (JOURNAL)
• what: The authors examined the reasons for ED use by patients who received CAR T therapy and their outcomes. The study shows that of patients presenting to ED within 6 months of CAR T_cell therapy, CRS and ICANS was present in 7.6% and 3.3%, respectively. The interpretation of these results should pay heed . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.